1558.HKライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (30 4月 2024 @ 17:08):

Stats
本日の出来高	3.68M
平均出来高	2.15M
時価総額	11.40B
EPS	HKD0 ( 2024-03-28 )
Last Dividend	HKD0.114 ( 2020-09-29 )
Next Dividend	HKD0 ( N/A )
P/E	5.31
ATR14	HKD0.0230 (0.18%)

ボリューム相関

長: -0.15 (neutral)

短: -0.43 (neutral)

Signal:(71.204) Neutral

YiChang HEC ChangJiang 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

YiChang HEC ChangJiang 相関 - 通貨/商品

0.61
( weak )

-0.21
( neutral )

0.00
( neutral )

0.24
( neutral )

0.17
( neutral )

YiChang HEC ChangJiang 財務諸表

Annual	2023
収益:	HKD6.29B
総利益:	HKD4.99B (79.21 %)
EPS:	HKD2.26

FY	2023
収益:	HKD6.29B
総利益:	HKD4.99B (79.21 %)
EPS:	HKD2.26

FY	2022
収益:	HKD3.74B
総利益:	HKD2.85B (76.00 %)
EPS:	HKD0.0871

FY	2021
収益:	HKD913.79M
総利益:	HKD483.70M (52.93 %)
EPS:	HKD-0.667

Financial Reports:

No articles found.

YiChang HEC ChangJiang Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

YiChang HEC ChangJiang Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 8.02 - good (80.17%) | Divividend Growth Potential Score: 4.29 - Potential for dividend initiation, but uncertain (14.13%)

Information

First Dividend	HKD0.0885	2016-06-08
Last Dividend	HKD0.114	2020-09-29
Next Dividend	HKD0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	9	--
Total Paid Out	HKD2.08	--
Avg. Dividend % Per Year	0.00%	--
Score	2.94	--
Div. Sustainability Score	8.02
Div.Growth Potential Score	4.29
Div. Directional Score	6.15	--

Next Divdend (Est)
(2024-07-24)

HKD0 Estimate 0.00 %

Dividend Stability

0.06 Very Bad

Dividend Score

2.94

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
9997.HK	Ex Dividend Knight	2023-05-30	Annually	0.00%
2202.HK	Ex Dividend Junior	2023-07-14	Annually	0.00%
1209.HK	Ex Dividend Knight	2023-09-12	Semi-Annually	0.00%
0288.HK	Ex Dividend Knight	2023-08-28	Semi-Annually	0.00%
3968.HK	Ex Dividend Knight	2023-07-05	Annually	0.00%
1786.HK	Ex Dividend Junior	2023-07-04	Sporadic	0.00%
0822.HK	Ex Dividend Junior	2023-06-05	Annually	0.00%
2362.HK	No Dividend Player	2023-06-01	Annually	0.00%
1349.HK	Ex Dividend Junior	2023-06-05	Annually	0.00%
0393.HK	Ex Dividend Knight	2023-09-14	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.317	1.500	3.67	5.50	[0 - 0.5]
returnOnAssetsTTM	0.156	1.200	4.79	5.75	[0 - 0.3]
returnOnEquityTTM	0.268	1.500	8.13	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.397	0.800	8.01	6.41	[1 - 3]
quickRatioTTM	0.869	0.800	9.59	7.67	[0.8 - 2.5]
cashRatioTTM	0.387	1.500	8.96	10.00	[0.2 - 2]
debtRatioTTM	0.205	-1.500	6.59	-9.88	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	1.415	2.00	9.53	10.00	[0 - 30]
freeCashFlowPerShareTTM	1.170	2.00	9.42	10.00	[0 - 20]
debtEquityRatioTTM	0.329	-1.500	8.68	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.792	1.000	0.132	0.132	[0.2 - 0.8]
operatingProfitMarginTTM	-1.141	1.000	-10.00	-10.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.477	1.000	8.46	8.46	[0.2 - 2]
assetTurnoverTTM	0.494	0.800	-0.0406	-0.0325	[0.5 - 2]
Total Score				8.02

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	5.19	1.000	9.58	0	[1 - 100]
returnOnEquityTTM	0.268	2.50	8.80	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	1.170	2.00	9.61	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	1.415	2.00	9.53	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.0801	1.500	-2.80	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.198	1.000	7.56	0	[0.1 - 0.5]
Total Score				4.29

YiChang HEC ChangJiang

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in the therapeutic areas of anti-virus, endocrine and metabolic diseases, and cardiovascular diseases in the People's Republic of China. It also manufactures and sells active pharmaceutical ingredients; researches and develops medical devices and drugs, as well as biotechnology; and provides medical consulting services. The company sells its products to hospitals and medical institutions through a network of distributors. It has a strategic cooperation framework agreement with Alibaba Health Technology (China) Limited to carry out influenza special projects; Jointown Pharmaceutical Group Co., Ltd.; Guangdong Yihao Pharmaceutical Co., Ltd.; and Shenzhen HEC Industrial Development Co., Ltd, as well as strategic cooperative partnership with China National Accord Medicines Corporation Ltd. The company was formerly known as Yichang Changjiang Pharmaceutical Company Limited and changed its name to YiChang HEC ChangJiang Pharmaceutical Co., Ltd. in May 2015. The company was incorporated in 2001 and is based in Yichang, China. YiChang HEC ChangJiang Pharmaceutical Co., Ltd. is a subsidiary of Guangdong HEC Technology Holding Co., Ltd.